Ann: Next Science receives EPA approval for Surface Disinfectant, page-48

Roadrunner in regards the 3M partnership something was clearly amiss as increasing sales (to an exciting degree) were suddenly nobbled - just as soon as 3M announced it was buying a company with a competitor product (that was worth more to it than BlastX), last May.
Apparently the NXS/3M contract DID have failsafe clauses if sales targets were not met ...and maybe these will have kicked in now that a year has passed?
But how’s the market?

As far as Zimmer, goes - ditto - how’s the market?
NXS has announced CoVid-19 contraction across the board.... it may be a little early to lump that in as a failed deal?

Also you were quite wrong predicting the shorts would suddenly go crazy after shares were released from escrow last month.

I don’t know what is going on with NXS, or why they seem to have put a high level board together but neglected an equally strong marketing arm, but I do know they have a spectacular product.
Hopefully it will one day be available in chemists and on supermarket shelves in a variety of forms, as well as in hospitals and, if so, these products should appeal to a wide target audience.

Why are you so attached and yet so negative please?

cheers